| Novo Nordisk Pharma AG - NovoEight 250 IE, Injektionspräparat | | 63014 | | 01 | | NovoEight 250 IE | | Injektionspräparat | | B02BD02 | | Coagulation Factor Viii | | 18.02.2014 | | |
| | Composition | | Praeparatio cryodesiccata: turoctocogum alfa 250 U.I., histidinum, saccharum, polysorbatum 80, natrii chloridum, methioninum, calcii chloridum dihydricum, pro vitro.
Solvens: natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 4 ml. | | Packungsbestandteile | | Praeparatio cryodesiccata: | | | Injection preparation | | | | | | | | Active Agent | Dose |
|---|
| Turoctocogum Alfa | 250 UI |
| | BAG: Active Agent | Dose |
|---|
| Turoctocogum Alfa | 250 UI |
| | | | Inactive agents |
|---|
| Calcium Chloride | | Histidine | | Methionine | | Sodium Chloride | | Polysorbatum 80 | | Saccharum |
| |
| Solvens | | | Injection preparation | | | | | | | | | BAG: Active Agent | Dose |
|---|
| Turoctocogum Alfa | 250 UI |
| | | | Inactive agents |
|---|
| Sodium Chloride |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Durchstechflasche(n) | 203.66 | 250.00 | B | SL | Yes |
|
|
